Pfizer CEO Albert Bourla said on Monday the drugmaker might move overseas manufacturing to its existing plants in the United ...

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life ...

As for Pfizer’s broader gene therapy plan, the company has been involved in a research collaboration with Beam Therapeutics focused on mRNA-delivered gene editing rather than viral vector-based ...

Pfizer (PFE) announced that James List has joined the company as Chief Internal Medicine Officer. List will oversee Pfizer’s Internal Medicine ...

March 6 (Reuters) - Pfizer (PFE.N), opens new tab on Thursday named James List as the head of the drugmaker's Internal Medicine portfolio, where he will oversee the development of its closely ...

People pose with syringe with needle in front of displayed Pfizer logo in this illustration taken. (credit: REUTERS) Before joining Pfizer in 2009, Dolsten held senior leadership roles at Wyeth ...

Pfizer generated strong growth last year despite a significant drop in COVID revenue. The company's business is solid, and its growth prospects are encouraging. Investors, however, remain ...

(Reuters) -Pfizer CEO Albert Bourla said on Monday the drugmaker might move overseas manufacturing to its existing plants in the United States, if required, as the Trump administration threatens ...

Pfizer Ltd on Friday said its board approved signing a marketing and supply agreement with Mylan Pharmaceuticals Pvt Ltd for two of its brands -- Ativan and Pacitane. Ativan is used for the treatment ...

A post is doing rounds on social media claiming that vaccine maker Pfizer's COVID vaccines have side effects including few fatal ones. The posts have shared a report with the logo of the US House ...

Pfizer stock has suffered as demand for the company’s top selling coronavirus products declined. The pharma giant has reached an important transition point. Right now, as an investor, you may be ...